Concurrently, our product team have been evaluating the potential for AI to enhance the efficiency of the Kneat Gx platform, and we expect to incorporate some AI capabilities into it this year.

Investing in TSX healthcare stocks such as Kneat.com can help Canadians generate outsized gains in 2025 and beyond.

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. KSIOF's gross margins have expanded to 75% by 2024, nearing EBITDA profitability ...

Kneat.com Inc (KSIOF) enhanced its Kneat Gx platform, offering improved features such as richer reporting dashboards and greater connectivity to enterprise systems. Operating expenses grew by 10% ...

which plan to leverage Kneat Gx to digitize their own processes as well as those of their customers. Throughout 2024, a number of business functions within Kneat leveraged AI tools to enhance ...